Neogenomics (NEO) Total Debt (2010 - 2020)

Neogenomics has reported Total Debt for 11 years, with the latest figure at $95.6 million in Q1 2020.

• For the quarter ending Q1 2020, Total Debt rose 642.68% year-over-year to $95.6 million; the trailing twelve-month figure through Mar 2020 stood at $95.6 million (up 642.68% YoY), and the FY2019 full-year result was $96.8 million, up 1.12% from the prior year.
• Total Debt for Q1 2020 stood at $95.6 million, down from $96.8 million in the prior quarter.
• The five-year high for Total Debt was $98.1 million in Q2 2018, with the low at $5.0 million in Q2 2019.
• Historically, Total Debt has averaged $46.5 million across 5 years, with a median of $30.7 million in 2017.
• Annual changes were most pronounced in 2019 — Total Debt slumped 94.9% — and 2020, when it jumped 642.68%.
• Neogenomics' Total Debt stood at $25.5 million in 2016, then rose by 10.63% to $28.3 million in 2017, then jumped by 238.76% to $95.8 million in 2018, then increased by 1.12% to $96.8 million in 2019, then retreated by 1.26% to $95.6 million in 2020.
• The last three Total Debt figures came in at $95.6 million (Q1 2020), $96.8 million (Q4 2019), and $6.2 million (Q3 2019), per Business Quant data.